ConductScience.org, home

Paper41526596

Adoptive T-cell therapies for persistent COVID-19 in immunocompromised patients: Comparison of IFN-γ virus-specific T-cell therapy and CD45RA+ T-cell depleted donor lymphocyte infusion.

Gopcsa L and 23 others. Geroscience, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Adoptive T-cell therapies for persistent COVID-19 in immunocompromised patients: Comparison of IFN-γ virus-specific T-cell therapy and CD45RA+ T-cell depleted donor lymphocyte infusion. Papers, record 41526596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41526596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adoptive T-cell therapies for persistent COVID-19 in immunocompromised patients: Comparison of IFN-γ virus-specific T-cell therapy and CD45RA+ T-cell depleted donor lymphocyte infusion.
PubMed
Journal
Geroscience
PubMed
Year
2026
PubMed
Publication types
Journal Article, Comparative Study
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gopcsa LLászlóhttps://orcid.org/0000-0003-4930-7049
2Petrik BRBorisz Rabánhttps://orcid.org/0009-0002-5898-368X
3Szabó BGBálint Gergelyhttps://orcid.org/0000-0003-1775-1356
4Réti MMariennhttps://orcid.org/0000-0002-4682-5628
5Andrikovics HHajnalkahttps://orcid.org/0000-0002-8368-9784
6Bobek IIlonahttps://orcid.org/0000-0003-2187-4666
7Bekő GGabriellahttps://orcid.org/0000-0001-8539-5897
8Bogyó JJudit
9Ceglédi AAndreahttps://orcid.org/0000-0002-4285-7518
10Dobos KKatalin
11Giba-Kiss LLaura
12Kis OOrsolya
13Lakatos BBotondhttps://orcid.org/0000-0001-7276-7639
14Mathiász DDóra
15Meggyesi NNóra
16Miskolczi GGottfried
17Németh NNoémi
18Sinkó JJánoshttps://orcid.org/0000-0001-7721-6828
19Szilvási AAnikóhttps://orcid.org/0000-0002-4092-6073
20Szlávik JJános

Source PubMed

See all 24 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Immunocompromised HostMajor topic
Interferon-gammaMajor topic
T-LymphocytesMajor topic
Immunotherapy, AdoptiveMajor topic
Lymphocyte TransfusionMajor topic
Humans
Female
Male
Middle Aged
Prospective Studies
Leukocyte Common Antigens
SARS-CoV-2
Adult
Aged
Hematopoietic Stem Cell Transplantation
Lymphocyte Depletion

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
TKP2021-EGA-08
'Project number TKP2021-EGA-08 has been implemented with support from the National Research, Development, and Innovation Fund of Hungary, financed under the 'Thematic Excellence Program 2021' funding scheme'.
PubMed

Source PubMed

Download CSV of grants

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134797216Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome.Acta Microbiol Immunol Hung2021https://conductscience.org/library/papers/34797216PubMed
240412763Advancing T-cell immunotherapy for cellular senescence and disease: Mechanisms, challenges, and clinical prospects.Ageing Res Rev2025https://conductscience.org/library/papers/40412763PubMed
336719907Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.PLoS Med2023https://conductscience.org/library/papers/36719907PubMed
436585293
Donor selection for adoptive cell therapy with CD45RA- memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release.
Cytotherapy2023https://conductscience.org/library/papers/36585293PubMed
539294134Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections.Nat Commun2024https://conductscience.org/library/papers/39294134PubMed
638593233Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients.Blood Adv2024https://conductscience.org/library/papers/38593233PubMed
737255929The ageing immune system as a potential target of senolytics.Oxf Open Immunol2023https://conductscience.org/library/papers/37255929PubMed
840100618Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective.Infect Dis Ther2025https://conductscience.org/library/papers/40100618PubMed
940214453Recent Advances in Aging and Immunosenescence: Mechanisms and Therapeutic Strategies.Cells2025https://conductscience.org/library/papers/40214453PubMed
1038321020Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment.NPJ Aging2024https://conductscience.org/library/papers/38321020PubMed
1139125624Revealing the Hidden Impacts: Insights into Biological Aging and Long-Term Effects in Pauci- and Asymptomatic COVID-19 Healthcare Workers.Int J Mol Sci2024https://conductscience.org/library/papers/39125624PubMed
1239944414Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised.Transfus Med Hemother2025https://conductscience.org/library/papers/39944414PubMed
1336374737A Primer on Chimerism Analysis: A Straightforward, Thorough Review.Lab Med2023https://conductscience.org/library/papers/36374737PubMed
1438212801Accelarated immune ageing is associated with COVID-19 disease severity.Immun Ageing2024https://conductscience.org/library/papers/38212801PubMed
1536776371Selective depletion of naïve T cells by targeting CD45RA.Front Oncol2022https://conductscience.org/library/papers/36776371PubMed
1640205403Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy.Infect Agent Cancer2025https://conductscience.org/library/papers/40205403PubMed
1737240647Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study.J Clin Med2023https://conductscience.org/library/papers/37240647PubMed
1838013358Immunosenescence and cancer: Opportunities and challenges.Medicine (Baltimore)2023https://conductscience.org/library/papers/38013358PubMed
1936517599The WHO estimates of excess mortality associated with the COVID-19 pandemic.Nature2023https://conductscience.org/library/papers/36517599PubMed
2038715113Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies.Virol J2024https://conductscience.org/library/papers/38715113PubMed

See all 94 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42713442Donor lymphocyte infusion as immune modulation after pediatric allogeneic transplantation.Blood Immunol Cell Ther2026https://conductscience.org/library/papers/42713442

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41526596

GET https://conductscience.org/api/papers/v1/41526596/authors?page=2